Home/BioXyTran/Ola Soderquist

OS

Ola Soderquist

CFO

Therapeutic Areas

Infectious Disease Cardiovascular Neurology Wound Care

BioXyTran Pipeline

Drug	Indication	Phase
ProLectin (BXT-25)	COVID-19 / SARS-CoV-2	Phase 2
BXT-25	Acute Respiratory Distress Syndrome (ARDS)	Preclinical

Leadership Team at BioXyTran

CMO & Medical Advisory Board Chief

View full BioXyTran profile